DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) had its price target lowered by Robert W. Baird from $31.00 to $24.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a neutral rating on the medical instruments supplier's stock.
Several other analysts have also recently commented on XRAY. Needham & Company LLC decreased their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research note on Friday, October 25th. Leerink Partners lowered DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research note on Thursday. StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Wednesday. Stifel Nicolaus lowered their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a research report on Thursday, July 18th. Finally, Evercore ISI cut their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a report on Tuesday, October 8th. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $29.50.
Check Out Our Latest Stock Analysis on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Up 3.5 %
Shares of DENTSPLY SIRONA stock traded up $0.60 during trading on Friday, reaching $17.86. The company's stock had a trading volume of 9,385,598 shares, compared to its average volume of 3,113,741. DENTSPLY SIRONA has a 1-year low of $17.22 and a 1-year high of $37.60. The company has a 50-day simple moving average of $24.82 and a two-hundred day simple moving average of $25.98. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57. The company has a market cap of $3.62 billion, a price-to-earnings ratio of -8.63, a P/E/G ratio of 1.31 and a beta of 1.02.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA's revenue was up .4% on a year-over-year basis. During the same period last year, the firm posted $0.49 EPS. As a group, equities analysts forecast that DENTSPLY SIRONA will post 1.98 earnings per share for the current year.
Institutional Trading of DENTSPLY SIRONA
A number of institutional investors and hedge funds have recently bought and sold shares of XRAY. Mirae Asset Global Investments Co. Ltd. increased its stake in DENTSPLY SIRONA by 8.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 40,015 shares of the medical instruments supplier's stock worth $1,328,000 after buying an additional 3,219 shares during the period. Daiwa Securities Group Inc. grew its stake in DENTSPLY SIRONA by 7.9% during the 1st quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier's stock worth $585,000 after purchasing an additional 1,296 shares in the last quarter. GSA Capital Partners LLP purchased a new stake in DENTSPLY SIRONA during the 1st quarter worth about $655,000. Texas Permanent School Fund Corp raised its position in DENTSPLY SIRONA by 4.4% in the 1st quarter. Texas Permanent School Fund Corp now owns 43,793 shares of the medical instruments supplier's stock valued at $1,453,000 after purchasing an additional 1,863 shares in the last quarter. Finally, Duality Advisers LP purchased a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at about $1,166,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.
About DENTSPLY SIRONA
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
